1006036-87-8,MFCD18251427
Catalog No.:AA008TF9

1006036-87-8 | Mk-2894

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
99%
1 week  
$304.00   $213.00
- +
10mg
99%
1 week  
$495.00   $347.00
- +
50mg
99%
1 week  
$1,924.00   $1,347.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008TF9
Chemical Name:
Mk-2894
CAS Number:
1006036-87-8
Molecular Formula:
C25H22F3NO3S
Molecular Weight:
473.5073
MDL Number:
MFCD18251427
SMILES:
OC(=O)c1ccc(cc1)C1(CC1)NC(=O)c1c(C)sc(c1Cc1ccc(cc1)C(F)(F)F)C
Properties
Computed Properties
 
Complexity:
725  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
5.9  

Literature

Title: The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.

Journal: Journal of medicinal chemistry 20100311

Title: MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.

Journal: The Journal of pharmacology and experimental therapeutics 20080501

Title: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Journal: Biochimica et biophysica acta 20000117

Title: Blouin M, Han Y, Burch J, Farand J, Mellon C, Gaudreault M, Wrona M, Lévesque JF, Denis D, Mathieu MC, Stocco R, Vigneault E, Therien A, Clark P, Rowland S, Xu D, O'Neill G, Ducharme Y, Friesen R.The discovery of 4-{1-[({2,5-dimethyl-4--(trifluoromethyl)benzyl-3-thienyl}carbonyl)aminocyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.J Med Chem. 2010 Mar 11;53(5):2227-38.

Title: Tijana Markovič, et al. Structural features of subtype-selective EP receptor modulators. Drug Discov Today. 2017 Jan;22(1):57-71.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1006036-87-8
Tags:1006036-87-8 Molecular Formula|1006036-87-8 MDL|1006036-87-8 SMILES|1006036-87-8 Mk-2894
Catalog No.: AA008TF9
1006036-87-8,MFCD18251427
1006036-87-8 | Mk-2894
Pack Size: 5mg
Purity: 99%
1 week
$304.00 $213.00
Pack Size: 10mg
Purity: 99%
1 week
$495.00 $347.00
Pack Size: 50mg
Purity: 99%
1 week
$1,924.00 $1,347.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008TF9
Chemical Name: Mk-2894
CAS Number: 1006036-87-8
Molecular Formula: C25H22F3NO3S
Molecular Weight: 473.5073
MDL Number: MFCD18251427
SMILES: OC(=O)c1ccc(cc1)C1(CC1)NC(=O)c1c(C)sc(c1Cc1ccc(cc1)C(F)(F)F)C
Properties
Complexity: 725  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 33  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 5.9  
Literature fold

Title: The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.

Journal: Journal of medicinal chemistry20100311

Title: MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.

Journal: The Journal of pharmacology and experimental therapeutics20080501

Title: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Journal: Biochimica et biophysica acta20000117

Title: Blouin M, Han Y, Burch J, Farand J, Mellon C, Gaudreault M, Wrona M, Lévesque JF, Denis D, Mathieu MC, Stocco R, Vigneault E, Therien A, Clark P, Rowland S, Xu D, O'Neill G, Ducharme Y, Friesen R.The discovery of 4-{1-[({2,5-dimethyl-4--(trifluoromethyl)benzyl-3-thienyl}carbonyl)aminocyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.J Med Chem. 2010 Mar 11;53(5):2227-38.

Title: Tijana Markovič, et al. Structural features of subtype-selective EP receptor modulators. Drug Discov Today. 2017 Jan;22(1):57-71.

Building Blocks More >
1204669-58-8
1204669-58-8
Epacadostat
AA008TJF | MFCD29075639
1095274-55-7
1095274-55-7
Ethyl 3-bromo-5-chlorobenzoate
AA008TN9 | MFCD10566220
1030613-69-4
1030613-69-4
3-Bromo-4,5-dihydroisoxazole-5-carboxylic acid amide
AA008TVT | MFCD11707008
112029-98-8
112029-98-8
(1-Methylpyrazol-4-yl)methanol
AA008U5T | MFCD01822311
1056629-20-9
1056629-20-9
Benzyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate
AA008UEU | MFCD17018653
1033743-79-1
1033743-79-1
3-(4-Methylpiperazin-1-ylsulfonyl)phenylboronic acid pinacol ester
AA008UOU | MFCD19288884
1209248-98-5
1209248-98-5
Methyl 6-(fluoromethyl)picolinate
AA008V08 | MFCD11109900
10227-64-2
10227-64-2
1-(1H-Benzimidazol-2-yl)-2-chloroethanone
AA008V60 | MFCD09864300
1135439-04-1
1135439-04-1
1-((6-Chloropyridin-3-yl)methyl)piperazine dihydrochloride
AA008VBM | MFCD11105784
1211489-11-0
1211489-11-0
1-(8-Methyl-5-quinolinyl)methanamine
AA008VGR | MFCD15204347
Submit
© 2017 AA BLOCKS, INC. All rights reserved.